OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
The HLA-G immune checkpoint: a new immuno-stimulatory role for the α1-domain-deleted isoform
Diana Tronik‐Le Roux, Marina Daouya, Alix Jacquier, et al.
Cellular and Molecular Life Sciences (2022) Vol. 79, Iss. 6
Closed Access | Times Cited: 14
Diana Tronik‐Le Roux, Marina Daouya, Alix Jacquier, et al.
Cellular and Molecular Life Sciences (2022) Vol. 79, Iss. 6
Closed Access | Times Cited: 14
Showing 14 citing articles:
Cancer cell-intrinsic PD-1: Its role in malignant progression and immunotherapy
Muhua Chen, Lei Bie, Ying Jieer
Biomedicine & Pharmacotherapy (2023) Vol. 167, pp. 115514-115514
Open Access | Times Cited: 25
Muhua Chen, Lei Bie, Ying Jieer
Biomedicine & Pharmacotherapy (2023) Vol. 167, pp. 115514-115514
Open Access | Times Cited: 25
Exploring Immune Checkpoint Inhibitors: Focus on PD-1/PD-L1 Axis and Beyond
Durre Aden, Samreen Zaheer, Niti Sureka, et al.
Pathology - Research and Practice (2025) Vol. 269, pp. 155864-155864
Closed Access | Times Cited: 1
Durre Aden, Samreen Zaheer, Niti Sureka, et al.
Pathology - Research and Practice (2025) Vol. 269, pp. 155864-155864
Closed Access | Times Cited: 1
Deciphering the complexities of cancer cell immune evasion: Mechanisms and therapeutic implications
Ishita Gupta, Ola Hussein, Konduru S. Sastry, et al.
Advances in Cancer Biology - Metastasis (2023) Vol. 8, pp. 100107-100107
Open Access | Times Cited: 19
Ishita Gupta, Ola Hussein, Konduru S. Sastry, et al.
Advances in Cancer Biology - Metastasis (2023) Vol. 8, pp. 100107-100107
Open Access | Times Cited: 19
miRNAs in Regulation of Tumor Microenvironment, Chemotherapy Resistance, Immunotherapy Modulation and miRNA Therapeutics in Cancer
Kousain Kousar, Tahir Ahmad, Maisa Siddiq Abduh, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 22, pp. 13822-13822
Open Access | Times Cited: 27
Kousain Kousar, Tahir Ahmad, Maisa Siddiq Abduh, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 22, pp. 13822-13822
Open Access | Times Cited: 27
Overview of splicing variation in ovarian cancer
Min Zhou, Mingyao Tian, Zhuoer Li, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2025), pp. 189288-189288
Closed Access
Min Zhou, Mingyao Tian, Zhuoer Li, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2025), pp. 189288-189288
Closed Access
Human Cytomegalovirus Antigen Presentation by HLA ‐G in Infected Cells
Mireia Altadill, Iñaki Álvarez, Michelle Ataya, et al.
HLA (2025) Vol. 105, Iss. 5
Open Access
Mireia Altadill, Iñaki Álvarez, Michelle Ataya, et al.
HLA (2025) Vol. 105, Iss. 5
Open Access
HLA-G 3’UTR polymorphism diplotypes and soluble HLA-G plasma levels impact cervical cancer susceptibility and prognosis
Jun Gan, Xing-Hong Di, Zi-Yi Yan, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 15
Jun Gan, Xing-Hong Di, Zi-Yi Yan, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 15
Interaction of immune cells with renal cancer development: Mendelian randomization (MR) study
Zhongwen Lü, Yu Yin, T. Rajeswara Rao, et al.
BMC Cancer (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 3
Zhongwen Lü, Yu Yin, T. Rajeswara Rao, et al.
BMC Cancer (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 3
Multiomics Analysis of Disulfidptosis Patterns and Integrated Machine Learning to Predict Immunotherapy Response in Lung Adenocarcinoma
Junzhi Liu, Huimin Li, Nannan Zhang, et al.
Current Medicinal Chemistry (2024) Vol. 31, Iss. 25, pp. 4034-4055
Closed Access | Times Cited: 3
Junzhi Liu, Huimin Li, Nannan Zhang, et al.
Current Medicinal Chemistry (2024) Vol. 31, Iss. 25, pp. 4034-4055
Closed Access | Times Cited: 3
Deciphering the role of alternative splicing in neoplastic diseases for immune-oncological therapies
Marcus Bauer, C. Schöbel, Claudia Wickenhauser, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 2
Marcus Bauer, C. Schöbel, Claudia Wickenhauser, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 2
Targeting of Non-Classical Human Leukocyte Antigens as Novel Therapeutic Strategies in Cancer
Javier David Benítez Fuentes, Jorge Bartolomé, Kauzar Mohamed Mohamed, et al.
Cancers (2024) Vol. 16, Iss. 24, pp. 4266-4266
Open Access | Times Cited: 2
Javier David Benítez Fuentes, Jorge Bartolomé, Kauzar Mohamed Mohamed, et al.
Cancers (2024) Vol. 16, Iss. 24, pp. 4266-4266
Open Access | Times Cited: 2
Peripheral HLA-G/ILT-2 immune checkpoint axis in acute and convalescent COVID-19 patients
Hana Rohn, Sabine Schramm, Krystallenia Pansikaki, et al.
Human Immunology (2023) Vol. 84, Iss. 8, pp. 393-400
Open Access | Times Cited: 3
Hana Rohn, Sabine Schramm, Krystallenia Pansikaki, et al.
Human Immunology (2023) Vol. 84, Iss. 8, pp. 393-400
Open Access | Times Cited: 3
Assessment of Impact of Human Leukocyte Antigen-Type and Cytokine-Type Responses on Outcomes after Targeted Therapy Currently Used to Treat Chronic Lymphocytic Leukemia
Mihaela Andreescu, Nicoleta Berbec, Alina Tănase
Journal of Clinical Medicine (2023) Vol. 12, Iss. 7, pp. 2731-2731
Open Access | Times Cited: 1
Mihaela Andreescu, Nicoleta Berbec, Alina Tănase
Journal of Clinical Medicine (2023) Vol. 12, Iss. 7, pp. 2731-2731
Open Access | Times Cited: 1
Special Issue: 9th International Conference on HLA-G
Pr Edgardo D. Carosella
Human Immunology (2023) Vol. 84, Iss. 8, pp. 357-358
Closed Access
Pr Edgardo D. Carosella
Human Immunology (2023) Vol. 84, Iss. 8, pp. 357-358
Closed Access
